| 4CTH: reference: Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease., Webster CI, Burrell M, Olsson LL, Fowler SB, Digby S, Sandercock A, Snijder A, Tebbe J, Haupts U, Grudzinska J, Jermutus L, Andersson C, PLoS One. 2014 Aug 4;9(8):e104001. doi: 10.1371/journal.pone.0104001. eCollection, 2014. PMID: 25089527 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).